Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (24)

2021

  1. Spinophilin expression in postmortem prefrontal cortex of schizophrenic subjects: Effects of antipsychotic treatment

    European Neuropsychopharmacology, Vol. 42, pp. 12-21

  2. α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects

    European Neuropsychopharmacology, Vol. 52, pp. 3-11

2019

  1. Differential α 2A - and α 2C -adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex

    Journal of Psychopharmacology, Vol. 33, Núm. 2, pp. 244-249

  2. Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins

    European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1453-1463

2016

  1. Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence

    World Journal of Biological Psychiatry, Vol. 17, Núm. 4, pp. 308-315

2015

  1. Up-regulated 14-3-3β and 14-3-3ζ proteins in prefrontal cortex of subjects with schizophrenia: Effect of psychotropic treatment

    Schizophrenia Research, Vol. 161, Núm. 2-3, pp. 446-451

2014

  1. Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: Differential effect of antidepressant treatment

    Journal of Affective Disorders, Vol. 167, pp. 343-350

2013

  1. Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment

    Psychopharmacology, Vol. 226, Núm. 1, pp. 177-188

2012

  1. Differential regulation of RGS proteins in the prefrontal cortex of short- and long-term human opiate abusers

    Neuropharmacology, Vol. 62, Núm. 2, pp. 1044-1051

  2. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

    Nature Neuroscience, Vol. 15, Núm. 9, pp. 1245-1254

2010

  1. Characterization of regulators of G-protein signaling RGS4 and RGS10 proteins in the postmortem human brain

    Neurochemistry International, Vol. 57, Núm. 7, pp. 722-729

2008

  1. Monoamine oxidase B activity is increased in human gliomas

    Neurochemistry International, Vol. 52, Núm. 1, pp. 230-234

  2. PRESENCE OF alpha(2C) DEL322-325 ADRENOCEPTOR GENE POLYMORPHISM IN SUBJECTS WITH DIFFERENT PSYCHIATRIC DISORDERS

    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY

2006

  1. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the μ-opioid receptor and I2-imidazoline binding sites

    Bioorganic and Medicinal Chemistry, Vol. 14, Núm. 19, pp. 6570-6580

2000

  1. Characterization of receptor-mediated [35S]GTPγS binding to cortical membranes from postmortem human brain

    European Journal of Pharmacology, Vol. 390, Núm. 1-2, pp. 25-36

1999

  1. Differential modulation of α2-adrenoceptor subtypes in rat kidney by chronic desipramine treatment

    Life Sciences, Vol. 64, Núm. 25, pp. 2327-2339

1996

  1. Mutations of Tyr326 in the β2-adrenoceptor disrupt multiple receptor functions

    European Journal of Pharmacology, Vol. 307, Núm. 2, pp. 243-250

  2. [3H]RX821002 [2-methoxyidazoxan) binds to α2-adrenoceptor subtypes and a non-adrenoceptor imidazoline binding site in rat kidney

    European Journal of Pharmacology, Vol. 316, Núm. 2-3, pp. 359-368

1995

  1. Increased density of μ-opioid receptors in the postmortem brain of suicide victims

    Brain Research, Vol. 682, Núm. 1-2, pp. 245-250

  2. Spontaneous Withdrawal from Long‐Term Treatment with Morphine Accelerates the Turnover of α2‐Adrenoceptors in the Rat Brain: Up‐Regulation of Receptors Associated with Increased Receptor Appearance

    Journal of Neurochemistry, Vol. 64, Núm. 6, pp. 2590-2597